These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 31677236)
41. Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract. Kurosaki F; Uchibori R; Mato N; Sehara Y; Saga Y; Urabe M; Mizukami H; Sugiyama Y; Kume A Gene Ther; 2017 May; 24(5):290-297. PubMed ID: 28346434 [TBL] [Abstract][Full Text] [Related]
42. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Müller OJ; Schinkel S; Kleinschmidt JA; Katus HA; Bekeredjian R Gene Ther; 2008 Dec; 15(23):1558-65. PubMed ID: 18615116 [TBL] [Abstract][Full Text] [Related]
43. AAV-DJ is superior to AAV9 for targeting brain and spinal cord, and de-targeting liver across multiple delivery routes in mice. Chauhan M; Daugherty AL; Khadir FE; Duzenli OF; Hoffman A; Tinklenberg JA; Kang PB; Aslanidi G; Pacak CA J Transl Med; 2024 Sep; 22(1):824. PubMed ID: 39237935 [TBL] [Abstract][Full Text] [Related]
44. Inverse zonation of hepatocyte transduction with AAV vectors between mice and non-human primates. Bell P; Wang L; Gao G; Haskins ME; Tarantal AF; McCarter RJ; Zhu Y; Yu H; Wilson JM Mol Genet Metab; 2011 Nov; 104(3):395-403. PubMed ID: 21778099 [TBL] [Abstract][Full Text] [Related]
45. Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases. Luo Y; Liu C; Cerbini T; San H; Lin Y; Chen G; Rao MS; Zou J Stem Cells Transl Med; 2014 Jul; 3(7):821-35. PubMed ID: 24833591 [TBL] [Abstract][Full Text] [Related]
55. Distributional comparison of different AAV vectors after unilateral cochlear administration. Han S; Xu Z; Wang S; Tang H; Hu S; Wang H; Guan G; Shu Y Gene Ther; 2024 Mar; 31(3-4):154-164. PubMed ID: 38097651 [TBL] [Abstract][Full Text] [Related]
56. Preparation and Administration of Adeno-associated Virus Vectors for Corneal Gene Delivery. Song L; Bower JJ; Hirsch ML Methods Mol Biol; 2020; 2145():77-102. PubMed ID: 32542602 [TBL] [Abstract][Full Text] [Related]
57. Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver. Qiao C; Yuan Z; Li J; He B; Zheng H; Mayer C; Li J; Xiao X Gene Ther; 2011 Apr; 18(4):403-10. PubMed ID: 21150938 [TBL] [Abstract][Full Text] [Related]
58. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies. Sun J; Hua B; Chen X; Samulski RJ; Li C Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688 [TBL] [Abstract][Full Text] [Related]
59. Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury. Griffin JM; Fackelmeier B; Fong DM; Mouravlev A; Young D; O'Carroll SJ Gene Ther; 2019 May; 26(5):198-210. PubMed ID: 30962538 [TBL] [Abstract][Full Text] [Related]
60. Systemic delivery of shRNA by AAV9 provides highly efficient knockdown of ubiquitously expressed GFP in mouse heart, but not liver. Piras BA; O'Connor DM; French BA PLoS One; 2013; 8(9):e75894. PubMed ID: 24086659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]